A long journey to treat epilepsy with the gut microbiota

• Published in: Frontiers in cellular neuroscience Vol. 18; p. 1386205
• Main Authors: Li, Qinrui, Gu, Youyu, Liang, Jingjing, Yang, Zhixian, Qin, Jiong
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 26-06-2024
• Subjects: brain–gut axis; Cellular Neuroscience; epilepsy; gut microbiota; ketogenic diet; probiotics; epilepsy; ketogenic diet; brain–gut axis; gut microbiota; probiotics
• ISSN: 1662-5102; 1662-5102
• DOI: 10.3389/fncel.2024.1386205

Epilepsy is a common neurological disorder that affects approximately 10.5 million children worldwide. Approximately 33% of affected patients exhibit resistance to all available antiseizure medications, but the underlying mechanisms are unknown and there is no effective treatment. Increasing evidence has shown that an abnormal gut microbiota may be associated with epilepsy. The gut microbiota can influence the function of the brain through multiple pathways, including the neuroendocrine, neuroimmune, and autonomic nervous systems. This review discusses the interactions between the central nervous system and the gastrointestinal tract (the brain-gut axis) and the role of the gut microbiota in the pathogenesis of epilepsy. However, the exact gut microbiota involved in epileptogenesis is unknown, and no consistent results have been obtained based on current research. Moreover, the target that should be further explored to identify a novel antiseizure drug is unclear. The role of the gut microbiota in epilepsy will most likely be uncovered with the development of genomics technology.